Are medical and nonmedical uses of large-scale genomic markers conflating genetics and 'race'?

Nature Genetics

Volumn 36, Issue 11 SUPPL. 1, 2004, Pages

  Rotimi, Charles N ^a  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA SEQUENCE; ENVIRONMENTAL FACTOR; ETHNOLOGY; GENE MAPPING; GENETIC VARIABILITY; GENOME; GENOMICS; GENOTYPE; HUMAN; PRIORITY JOURNAL; RACE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; ARTICLE; GENETIC MARKER; GENETICS; SOCIAL BEHAVIOR;

CONTINENTAL POPULATION GROUPS; GENETIC MARKERS; GENOME, HUMAN; HUMANS; SOCIAL IDENTIFICATION; VARIATION (GENETICS);

EID: 16544381463     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1439     Document Type: Review

References (71)

1. Bamshad, M et al. Deconstructing the relationship between genetics and race. Nat. Rev. Genet. 5, 598-608 (2004).
2. Shriver, M.D. & Kittles, R.A. Genetic ancestry and the search for personalized genetic histories. Nat. Rev. Genet. 5, 611-618 (2004).
3. Botstein, D. & Risch, N. Discovering genotypes underlying human phenotypes: Past successes for mendelian disease, future approaches for complex. Nat. Genet. 33 Suppl, 228-237 (2003).
4. The International HapMap Project. Nature 426, 789-796 (2003).
5. International HapMap Consortium. Integrating ethics and science in the International HapMap Project. Nat. Rev. Genet. 5, 467-475 (2004).
6. Lazarou, J., Pomeranz, B.H. & Corey, P.N. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 15, 200-205 (1998).
7. Nebert, D.W. & Menon, A.G. Pharmacogenomics, ethnicity, and susceptibility genes. Pharmacogenomics J. 1, 19-22 (2001).
8. Deloukas P, Bentley D. The HapMap project and its application to genetic studies of drug response. Pharmacogenomics J. 4, 88-90 (2004).
9. Sankar, P. & Cho, M.K. Genetics. Toward a new vocabulary of human genetic variation. Science 298, 1337-1338 (2002).
10. Risch, N., Burchard, E., Ziv, E. & Tang, H. Categorization of humans in biomedical research: genes, race and disease. Genome Biol. 1, 3 (2002).
11. Ellison, G.T.H. & De Wet, T. 'Race', ethnicity and the psychopathology of social identity. in Psychopathology and Social Prejudice (eds. Hook, D. & Eagle, G.) 130-149 (Cape Town, Juta, 2002).
12. Ellison, G.T.H. & Jones, I.R. Social identities and the 'new genetics': Scientific and social consequences. Critical Public Health 12, 265-282 (2002).
13. Foster, M.W. & Sharp, R.R. Race, ethnicity, and genomics: social classifications as proxies of biological heterogeneity. Genome Res. 12, 44-50 (2002).
14. Pritchard, J.K. Are rare variants responsible for susceptibility to complex diseases? Am. J. Hum. Genet. 69, 124-137 (2001).
15. Pritchard, J.K. & Cox, N.J. The allelic architecture of human disease genes: common disease-common variant...or not? Hum. Mol. Genet. 11, 2417-2423 (2002).
16. Bell, J. Predicting disease using genomics. Nature 429, 453-456 (2004).
17. Van Eerdewegh, P. et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 25, 426-430 (2002).
18. Allen, M. et al. Positional cloning of a novel gene influencing asthma from chromosome 2q14. Nat. Genet. 35, 258-263 (2003).
19. van de Vijver, M.J. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 25, 347 (2002).
20. Dorman, J.S., LaPorte, R.E., Stone, R.A. & Trucco, M. Worldwide differences in the incidence of type I diabetes are associated with amino acid variation at position 57 of the HLA-DQ beta chain. Proc. Natl. Acad. Sci. USA 87, 7370-7374 (1990).
21. Altshuler, D. et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat. Genet. 26, 76-80 (2000).
22. Bell, G.I., Horita, S. & Karam, J.H. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes 33, 176-183 (1984).
23. Strittmatter, W.J. & Roses, A.D. Apolipoprotein E and Alzheimer's disease. Annu. Rev. Neurosci. 19, 53-77 (1996).
24. Dahlback, B. Resistance to activated protein C due to factor V R506Q mutation as a cause of venous thrombosis. Rev. Invest. Clin. 49 Suppl, 3-5 (1997).
25. Hugot, J.P. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603 (2001).
26. Ogura, Y. et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606 (2001).
27. Stefansson, H. et al. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 71, 877-892 (2002).
28. Gretarsdottir, S. et al. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat. Genet. 35, 131-138 (2003).
29. Carlson, C.S., Eberle, M.A., Kruglyak, L. & Nickerson, D.A. Mapping complex disease loci in whole-genome association studies. Nature 429, 446-452 (2004).
30. Daly, M.J., Rioux, J.D., Schaffner, S.F., Hudson, T.J. & Lander, E.S. High-resolution haplotype structure in the human genome. Nat. Genet. 29, 29-32 (2001).
31. Risch, N.J. Searching for genetic determinants in the new millennium. Nature 405, 847-856 (2000).
32. Goldstein, D.B. & Weale, ME. Population genomics: linkage disequilibrium holds the key. Curr. Biol. 11, 576-579 (2001).
33. Clark, A.G. Finding genes underlying risk of complex disease by linkage disequilibrium mapping. Curr. Opin. Genet. Dev. 13, 296-302 (2003).
34. Cardon, L.R. & Abecasis, G.R. Using haplotype blocks to map human complex trait loci. Trends Genet. 19, 135-140 (2003).
35. Tishkoff, S.A. & Williams, S.M. Genetic analysis of African populations: human evolution and complex disease. Nat. Rev. Genet. 3, 611-621 (2002).
36. Weiss, K.M. & Clarke, A.G. Linkage disequilibrum and the mapping of complex human traits. Trends Genet. 18, 19-24 (2002).
37. Tishkoff, S.A. & Verrelli, B.C. Patterns of human genetic diversity: implications for human evolutionary history and disease. Annu. Rev. Genomics Hum. Genet. 4, 293-340 (2003).
38. Kittles, R.A. & Weiss, K.M. Race, ancestry, and genes: implications for defining disease risk. Annu. Rev. Genomics 4, 33-67 (2003).
39. King, P.A. Gene Mapping: Using Law and Ethics As Guides (eds. Annas, G.J. & Elias, S.) 94-111 (Oxford University Press, Oxford, 1992).
40. Clayton, E.W. The complex relationship of genetics, groups, and health: what it means for public health. J. Law Med. Ethics 30, 290-297 (2002).
41. Tishkoff, S.A. et al. Haplotype diversity and linkage disequilibrium at human G6PD: recent origin of alleles that confer malarial resistance. Science 293, 455-462 (2001).
42. Smedley, A. Race in North America: Origin and Evolution of a Worldview 2nd edn (Westview, Boulder, 1999).
43. Juengst, E. Group identity and human diversity: Keeping biology straight from culture. Am. J. Hum. Genet. 63, 673-677 (1998).
44. Yu, N., Fu, Y.X. & Li, W.H. DNA polymorphism in a worldwide sample of human x chromosomes. Mol. Biol. Evol. 19, 2131-2141 (2002).
45. Cann, R.L., Stoneking, M. & Wilson, A.C. Mitochondrial DNA and human evolution. Nature 3, 31-36 (1987).
46. Barbujani, G., Magagni, A., Minch, E. & Cavalli-Sforza, L.L.An apportionment of human DNA diversity. Proc. Natl. Acad. Sci. USA 94, 4516-4519 (1997).
47. Rosenberg, N.A. et al. Genetic structure of human populations. Science 298, 2381-2385 (2002).
48. Bamshad, M.J. et al. Human population genetic structure and inference of group membership. Am. J. Hum. Genet. 72, 578-589 (2003).
49. Anonymous. Slicing soup. Nat. Biotechnol. 20, 637 (2002).
50. Olson, S. The genetic archaeology of race. The Atlantic Monthly April (2001).
51. Reich, D.E. et al. Linkage disequilibrium in the human genome. Nature 411, 99-204 (2001).
52. Gabriel, S.B. et al. The structure of haplotype blocks in the human genome. Science 21, 2225-2229 (2002).
53. Molnar, S. Human Variation: Races, Types and Ethic Groups 5th edn. (Prentice Hall, New Jersey, 2001).
54. Luzzatto, L. & Metha, A. Glucose-6-phosphate dehydrogenase deficiency. in The Metabolic Basis of Inherited Disease 5th edn. (eds. Scriver, C.R., Beaudet, A.L., Sly, W.S. & Valle D.) 3367-3398 (McGraw-Hill, New York, 1995).
55. Beutler, E., Vulliamy, T. & Luzzatto, L. Hematologically important mutations: glucose-6-phosphate dehydrogenase. Blood Cells Mol. Dis. 22, 49-56 (1996).
56. Braun, L. Race, ethnicity, and health: can genetics explain disparities? Perspect. Biol. Med. 45, 159-174 (2002).
57. Kevles, D.J. In the Name of Eugenics: Genetics and the Uses of Human Heredity (Harvard University Press, Cambridge, 1995).
58. Witzig, R. The medicalization of race: scientific legitimization of a flawed social construct. Ann. Intern. Med. 125, 675-679 (1996).
59. Cooper, R.S., Kaufman, J.S. & Ward, R. Race and genomics. N. Engl. J. Med. 348, 1166-1170 (2003).
60. Farrer, L.A. et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278, 1349-1356 (1997).
61. Burchard, E.G. et al. The importance of race and ethnic background in biochemical research and clinical practice. N. Engl. J. Med. 348, 1170-1175 (2003).
62. Halusha, M.K. et al. Patterns of single nucleotide polymorphisms in candidate genes for blood pressure homeostasis. Nat. Genet. 22, 239-247 (1999).
63. Wilson, J.F. et al. Population genetic structure of variable drug response. Nat. Genet. 29, 265-269 (2001).
64. Duster, T. Unlikely mix - Race, biology and drugs. The San Francisco Chronicle (2003).
65. Taylor, A.L., Cohn, J.N., Worcel, M., Franciosa, J.A. & A-HeFT Investigators. The African-American Heart Failure Trial: background, rationale and significance. J. Natl. Med. Assoc. 94, 762-769 (2002).
66. Pollack, A. Drug approved for heart failure in black patients. New York Times (2004).
67. Anonymous. Genes, drugs and race. Nat. Genet. 29, 239-240 (2003).
68. Cooper, R.S. & Psaty, B.M. Genomics and medicine: distraction, incremental progress, or the dawn of a new age? Ann. Intern. Med. 138, 576-580 (2003).
69. Kahn, J. Getting the numbers right: statistical mischief and racial profiling in heart failure research. Perspect. Biol. Med. 46, 473-483 (2003).
70. Kahn, J. How a drug becomes "ethnic": Law, Commerce and the production of racial categories in medicine. Yale J. Health Policy Law Ethics VI:I, 1-46 (2004).
71. Pollack, A. DNA of blacks to be gathered to fight illness. New York Times (2003).